Lorina Dudkin

761 total citations
5 papers, 647 citations indexed

About

Lorina Dudkin is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Lorina Dudkin has authored 5 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 1 paper in Neurology and 1 paper in Oncology. Recurrent topics in Lorina Dudkin's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Neuroblastoma Research and Treatments (1 paper) and Mast cells and histamine (1 paper). Lorina Dudkin is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Neuroblastoma Research and Treatments (1 paper) and Mast cells and histamine (1 paper). Lorina Dudkin collaborates with scholars based in United States. Lorina Dudkin's co-authors include Peter J. Houghton, Michael B. Dilling, Franklin C. Harwood, R. L. Travis, Christopher L. Morton, Raushan T. Kurmasheva, Pamela J. Cheshire, Melinda G. Hollingshead, Edward A. Sausville and Susan G. Arbuck and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Lorina Dudkin

5 papers receiving 631 citations

Peers

Lorina Dudkin
Elisabeth Llonch Switzerland
Brianne Kaiser United States
Rebecca L. Lynch United States
Michel Maira Switzerland
Lou Savas United States
B. Markman Australia
Margaret H. Veldman-Jones United Kingdom
Heather Knowles United States
Meraj Aziz United States
Donald P. Lesslie United States
Elisabeth Llonch Switzerland
Lorina Dudkin
Citations per year, relative to Lorina Dudkin Lorina Dudkin (= 1×) peers Elisabeth Llonch

Countries citing papers authored by Lorina Dudkin

Since Specialization
Citations

This map shows the geographic impact of Lorina Dudkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorina Dudkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorina Dudkin more than expected).

Fields of papers citing papers by Lorina Dudkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorina Dudkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorina Dudkin. The network helps show where Lorina Dudkin may publish in the future.

Co-authorship network of co-authors of Lorina Dudkin

This figure shows the co-authorship network connecting the top 25 collaborators of Lorina Dudkin. A scholar is included among the top collaborators of Lorina Dudkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorina Dudkin. Lorina Dudkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Bhagwat, Shripad V., Prafulla C. Gokhale, Andrew P. Crew, et al.. (2011). Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin. Molecular Cancer Therapeutics. 10(8). 1394–1406. 159 indexed citations
2.
Kurmasheva, Raushan T., Lorina Dudkin, Catherine A. Billups, et al.. (2009). The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma. Cancer Research. 69(19). 7662–7671. 132 indexed citations
3.
Fouladi, Maryam, Wayne L. Furman, Thomas K. Chin, et al.. (2006). Phase I Study of Depsipeptide in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Report. Journal of Clinical Oncology. 24(22). 3678–3685. 70 indexed citations
4.
Dilling, Michael B., Glen S. Germain, Lorina Dudkin, et al.. (2002). 4E-binding Proteins, the Suppressors of Eukaryotic Initiation Factor 4E, Are Down-regulated in Cells with Acquired or Intrinsic Resistance to Rapamycin. Journal of Biological Chemistry. 277(16). 13907–13917. 87 indexed citations
5.
Dudkin, Lorina, Michael B. Dilling, Pamela J. Cheshire, et al.. (2001). Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.. PubMed. 7(6). 1758–64. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Llonch Breakdown of academic impact, for papers by Brianne Kaiser Breakdown of academic impact, for papers by Rebecca L. Lynch Breakdown of academic impact, for papers by Michel Maira Breakdown of academic impact, for papers by Lou Savas Breakdown of academic impact, for papers by B. Markman Breakdown of academic impact, for papers by Margaret H. Veldman-Jones Breakdown of academic impact, for papers by Heather Knowles Breakdown of academic impact, for papers by Meraj Aziz Breakdown of academic impact, for papers by Donald P. Lesslie
Rankless by CCL
2026